Yuranus Infrastructure reports standalone net profit of Rs 0.80 crore in the March 2026 quarter

April 18, 2026 · 9:04 am IST Source: Business Standard
๐Ÿ“Œ

Key Takeaways

  • Sales rose 60.58% to Rs 6.07 crore in the quarter ended March 2026 as against Rs 3.78 crore during the previous quarter ended March 2025.
  • Sales declined 60.67% to Rs 10.80 crore in the year ended March 2026 as against Rs 27.46 crore during the previous year ended March 2025.
  • Sales rise 60.58% to Rs 6.07 crore Net profit of Yuranus Infrastructure reported to Rs 0.80 crore in the quarter ended March 2026 as against net loss of Rs 0.16 crore during the previous quarter ended March 2025.
  • For the full year,net profit reported to Rs 0.48 crore in the year ended March 2026 as against net loss of Rs 0.44 crore during the previous year ended March 2025.

Full Report

Sales rise 60.58% to Rs 6.07 crore
Net profit of Yuranus Infrastructure reported to Rs 0.80 crore in the quarter ended March 2026 as against net loss of Rs 0.16 crore during the previous quarter ended March 2025. Sales rose 60.58% to Rs 6.07 crore in the quarter ended March 2026 as against Rs 3.78 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.48 crore in the year ended March 2026 as against net loss of Rs 0.44 crore during the previous year ended March 2025. Sales declined 60.67% to Rs 10.80 crore in the year ended March 2026 as against Rs 27.46 crore during the previous year ended March 2025.

Originally reported by Business Standard.
๐Ÿ’ก

IPO Cracker Take

This market development has implications for IPO investors tracking upcoming issues. See our IPO calendar and live GMP data for the most recent moves.

โ“

Frequently Asked Questions

Market news feeds into IPO pricing decisions, subscription timing, and listing-day sentiment. Track the broader market daily alongside each active IPO's own fundamentals.

Our IPO calendar shows all upcoming, open, and recently listed issues in one place — with price band, GMP, and subscription data.

We publish daily market and IPO news, live GMP updates, and subscription tracking. Bookmark our News page or follow us on social media for real-time updates.
0 Comments

No comments yet. Be the first to share your opinion!